The Veterinary AI Scribe
Buyer's Framework

What this guide is for

AI scribes are everywhere in veterinary medicine right now. The demos are polished, the promises are big, and the pressure to adopt is real. As a practicing DVM who also consults on AI implementation for veterinary practices, I've seen both sides of this. Done well, a scribe genuinely gives you time back. Done poorly, it creates a new category of risk inside your medical records.

This guide is built for practice owners, medical directors, and managers who want to make a defensible, evidence-based decision. Not for the practice that wants to be first. For the practice that wants to be right.

The major players, side by side

These are the platforms worth evaluating as of May 2026. Organized by what they are actually best suited for, not by marketing claims. Prices are published rates where available.

Pricing at a glance

Medication and dosing risk. This is not theoretical.

Every AI scribe on this list can generate plausible-sounding notes. The danger is not the obvious errors. It is the quiet ones. A note that reads fluently but contains an incorrect drug name, a wrong dose, a missing route, or an omitted negative finding. These look like finished documentation. They are not.

Specific failure modes to understand before you start a pilot:

• Drug name confusion. Similar-sounding names get swapped, especially in noisy rooms. Brand and generic mismatch. Sometimes the model converts a brand to a common human medication pattern.
• Dosing and unit errors. Weight-based dosing creates a convergence of numeric transcription errors, unit mistakes, and concentration assumptions. mg vs. mL vs. mcg, route and frequency confusion.
• Abbreviation expansion. SID, SQ, SC, IM, and clinic-specific shorthand are context-dependent. An incorrect expansion looks clean in the final note.
• Hallucinations. LLMs can produce plausible-sounding but invented content: instructions not given, findings not stated, plans not discussed.
• Omissions of key negatives. A missing "no vomiting, no diarrhea" changes clinical interpretation on a future visit. Easy to miss in a fast review.
• Multi-patient exam bleed. When two or more pets from the same household are seen in the same appointment, exam findings frequently bleed across records. The scribe may attribute findings from one patient to the other's note, or pool abnormals into both records, requiring time-consuming manual sorting. This risk is highest when patients are seen back-to-back without an explicit verbal reset between them. See Question 11 for how to test this before you commit.

11 questions to ask before you sign

Write these down. Ask them out loud in the demo. Note the exact answer, not the impression. Vague responses to any of these are information.

1. Show me the full workflow from start recording to signed note. How does a clinician start and stop? What happens if they forget to stop? How is the note reviewed and committed? What is the fastest safe workflow on a busy day?
2. How do you handle medications, dosing, and abbreviations? Do you highlight meds and doses for verification? Can we add custom vocabulary and define preferred expansions? What happens when the tool is unsure, does it flag or guess?
3. What are your known failure modes, and what safeguards exist? Any vendor that claims they do not see hallucinations is not operating like a clinical tool. Push for specifics.
4. Can it separate speakers reliably in a noisy exam room? Test in your worst room, not their best demo. Overlapping speech, barking, fast medication discussions, client interruptions.
5. Where does the audio go, how long is it retained, and who can access it? Default retention, who on their staff can access recordings, and whether you can enforce deletion with written confirmation.
6. Is our data used for model training? Opt-in or opt-out? Where is it in the contract? What do third-party LLM providers do with it? Ask for a current subprocessor list.
7. What does and does not write back to our PIMS? Which integrations are live today, not roadmap? What do they read and what do they write back? Can it land in the correct patient record without manual matching?
8. What reporting proves time saved and note quality? Median time per note, review time, error tracking, adoption by clinician. Analytics on an enterprise-only tier is a signal.
9. What does a safe 30-day pilot look like? Which visit types should be excluded? What are reasonable stop rules for medication errors or invented findings? What can be tuned mid-pilot?
10. What are the contract terms, pricing model, and exit rights? Auto-renewal, cancellation notice window, data export rights, deletion guarantees. If leaving is painful, that is a design choice, not an accident.
11. How does the tool handle multi-patient appointments, and can it keep records cleanly separated? This is a real-world workflow that most demos never show you. When two or more pets from the same household are seen in the same visit, a common and significant failure mode is exam findings from one patient bleeding into the other's record. Abnormal findings in particular tend to appear in both notes unless the clinician is very explicit about naming the patient for every finding, every time. Before you commit to any tool, run a scripted test: see two patients back-to-back, give each distinct findings, and review both output notes for cross-contamination. Ask the vendor how the tool handles patient switching mid-encounter, whether it requires a manual reset between patients, and what the failure behavior looks like when it gets confused. If they cannot answer this clearly or have never tested it, that is information.

How to run a 30-day pilot that produces real evidence

A good pilot is not "let's try it and see." It is structured, scoped, and measurable. It answers one specific question: does this tool produce safe, accurate notes in our actual clinical environment, with our actual team, on our actual busy days?

Red flags that should make you pause

If you hear any of these during a demo or vendor conversation, treat it as information about how the company thinks about clinical risk.

• "Just copy and paste, it's fast."
• "We don't see hallucinations."
• "Our accuracy is very high." (Ask for the evidence, not the demo.)
• "We store audio by default and can't change retention."
• "We don't disclose subprocessors."
• "We can't guarantee deletion."
• "It works best if your doctors change how they talk."
• "Reporting is only available on our top tier."
• "Doctors just read it quickly." (This is a governance answer, not a quality answer.)
• "We haven't tested multi-patient appointments specifically." (This happens constantly in general practice. If they haven't tested it, you will be the one finding the bugs.)

Buy now, or wait?

Waiting is not failure. It is risk management. Here is how to think about timing honestly.